Experts Warn of Accuracy and Privacy Risks as AI Health Gadgets Take Centre Stage at CES

A wave of artificial intelligence powered health gadgets showcased at the annual technology trade show has drawn growing scepticism from medical and technology experts, who say enthusiasm is running ahead of evidence. While many of the products promise to revolutionise personal healthcare, specialists caution that questions around accuracy, reliability and data privacy remain largely unresolved.

At this year’s Consumer Electronics Show, dozens of companies unveiled AI driven devices claiming to track vital signs, detect illness early or offer personalised health advice. Products ranged from wearable sensors that monitor blood pressure and glucose levels to smart mirrors and earbuds designed to analyse physical and mental wellbeing in real time. For consumers, the appeal lies in convenience and the promise of proactive healthcare outside traditional clinical settings.

However, health professionals warn that many of these gadgets operate in a regulatory grey area. Unlike medical devices used in hospitals, a significant number of consumer health technologies are not required to undergo rigorous clinical trials. Experts say this raises concerns about whether the data generated is accurate enough to inform meaningful health decisions.

Several clinicians have pointed out that even small measurement errors can have serious consequences if users rely on AI generated insights without professional guidance. A device that incorrectly flags a health issue could cause unnecessary anxiety, while a false sense of reassurance might delay proper diagnosis and treatment. In both cases, experts stress that unverified technology should not replace established medical evaluation.

Technology specialists have also raised alarms about data handling practices. Many AI health gadgets rely on continuous data collection, often uploading sensitive personal information to cloud based platforms for analysis. This creates potential vulnerabilities, particularly if companies lack strong safeguards or clear policies on data storage, sharing and retention.

Privacy advocates argue that health data is among the most sensitive categories of personal information, yet consumers are often unaware of how extensively it is used. In some cases, user agreements allow companies to share anonymised data with third parties, a practice critics say can still pose risks if datasets are reidentified or misused.

The rapid pace of innovation has also outstripped the ability of regulators to keep up. While some countries are developing frameworks for digital health and AI oversight, standards vary widely, leaving consumers with uneven protection depending on where products are sold and used. Experts say clearer global guidelines are needed to distinguish wellness tools from medical devices and to define accountability when AI driven health advice goes wrong.

Despite the concerns, specialists acknowledge that AI has genuine potential to improve healthcare outcomes if applied responsibly. Properly validated tools could help manage chronic conditions, expand access to care and support early detection of disease, particularly in under resourced settings. The challenge lies in balancing innovation with evidence and ethics.

For now, experts urge consumers to approach AI health gadgets with caution. They recommend viewing these products as supplementary tools rather than diagnostic authorities, and to consult healthcare professionals before acting on any health related insights. As AI continues to enter the personal health space, trust, transparency and scientific validation are likely to determine whether these technologies become meaningful aids or costly distractions.